Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information
NCT04853160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24046
Last updated 2021-04-27
Summary
The prescribing information provides information on medicines. This study will check the number of patients starting febuxostat and the number of febuxostat users with cardiovascular disease after changes to the prescribing information.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-15
- Primary Completion
- 2021-01-05
- Completion
- 2021-01-05
Countries
- United States
Study Locations
More Related Trials
-
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
NCT02252835 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
NCT01416402 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
NCT00174915 ·Status: COMPLETED ·Phase: PHASE3
-
Lesinurad and Febuxostat Combination Extension Study in Gout
NCT01808144 ·Status: COMPLETED ·Phase: PHASE3
-
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
NCT03372200 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety of Febuxostat in Subjects With Gout.
NCT00174941 ·Status: COMPLETED ·Phase: PHASE2
-
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
NCT01701622 ·Status: TERMINATED ·Phase: NA
-
Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout
NCT02500641 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
NCT05109936 ·Status: RECRUITING ·Phase: PHASE3
-
CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
NCT02579096 ·Status: COMPLETED ·Phase: PHASE4
-
Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy
NCT01984749 ·Status: UNKNOWN ·Phase: NA
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
NCT01077284 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
NCT06603142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06139393 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
NCT00174967 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
NCT02139046 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients
NCT04155918 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
NCT05007392 ·Status: COMPLETED ·Phase: PHASE3
-
The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout
NCT03131583 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
NCT01350388 ·Status: COMPLETED ·Phase: NA